CRISPR/Cas9 induced KO of HuR in BC cell line MDA-MB-231 and pancreatic cancer cell line MIAPaCa2 led to significant reduction of PD-L1 protein levels in comparison with that of sgControl (Fig. 1c). This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.